Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lineage tracing from cellular heritage to disease destiny.

Nature genetics·2026
Same author

Editorial: Exploring cutaneous drug-related and drug-associated adverse events: from clinical insight to therapeutic management.

Frontiers in medicine·2026
Same author

The "Cairo Accord"- towards the eradication of RHD: revisited (2026).

Frontiers in cardiovascular medicine·2026
Same author

CD4<sup>+</sup> Tregs Drive Post-Ischemic Sprouting Angiogenesis via Endothelial YY1/MAML1 Reactivation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

METTL14 inhibits atherogenesis by epigenetically activating PPAR-α/γ transcription and fatty acid oxidation in VSMCs.

Cardiovascular research·2026
Same author

Nanoparticle approaches for hepatitis therapy and clinical translation.

Discover nano·2026

Related Experiment Video

Updated: Apr 16, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K

Reprogramming for cardiac regeneration.

Christophe Michel Raynaud1, Faizzan Syed Ahmad, Mona Allouba2

  • 1Qatar Cardiovascular Research Center, Qatar Foundation-Education City, Doha, Qatar.

Global Cardiology Science & Practice
|March 13, 2015
PubMed
Summary
This summary is machine-generated.

Cardiovascular disease treatment is difficult due to limited heart muscle regeneration. This research explores reprogramming strategies for creating new cardiomyocytes, discussing methods, potential, and challenges for clinical use.

More Related Videos

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.9K
Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K
In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.9K
Assessing Cardiac Reprogramming using High Content Imaging Analysis
06:02

Assessing Cardiac Reprogramming using High Content Imaging Analysis

Published on: October 26, 2020

1.5K

Area of Science:

  • Cardiovascular medicine
  • Regenerative medicine
  • Cell biology

Background:

  • Cardiovascular diseases pose significant challenges due to the heart's limited capacity for muscle regeneration.
  • Developing strategies to generate new cardiomyocytes is crucial for treating heart damage.

Purpose of the Study:

  • To review current reprogramming strategies for generating cardiomyocytes.
  • To discuss the choice of cells, methodologies, and future clinical challenges.

Main Methods:

  • Literature review of reprogramming strategies.
  • Analysis of cell sources and differentiation protocols.
  • Evaluation of in vitro and in vivo approaches.

Main Results:

  • Reprogramming offers a promising avenue for cardiomyocyte generation.
  • Various cell types and methods exist, each with unique advantages.
  • Significant challenges remain before clinical translation.

Conclusions:

  • Reprogramming strategies hold potential for cardiovascular disease therapy.
  • Further research is needed to overcome barriers to clinical application.